SUMMARY A simple and rapid method for the measurement of cobalamin bound intrinsic factor (Cbl-IF) complex and intrinsic factor binding antibody is described. The method is based on the principle of affinity chromatography and adapted to a batch separation technique. A specific ligand staphylococcal protein A was coupled to Sepharose to form a convenient solid phase matrix. The intrinsic factor binding antibody in patients with pernicious anaemia was used to form an immune complex with Cbl-IF. This complex was adsorbed on to staphylococcal protein A. Gastricjuice from control subjects and patients with pernicious anaemia was assayed for intrinsic factor activity and the results correlated very closely with two other established methods. Sera from 30 control subjects were assayed for binding intrinsic factor antibody and all were found to be negative; of 15 patients with pernicious anaemia, six were positive. These patients were selected with blocking antibody. The method does not require technologically advanced protein separation techniques and could therefore be applied in any clinical laboratory using radioisotopes. It could also be adapted to assay cobalamin in body fluids or in food.
The measurement of cobalamin bound intrinsic factor (Cbl-IF) complex is important in the study of the physiology and pathology of Cbl absorption. Alth 10 pg/l, specific activity 0-5 pCi/pg (18-5 kBq/ pg). The solution was checked for Cbl content using Euglena gracilis assay'4 for purity using column chromatography and stored in the dark at 4°C.
GASTRIC JUICE
Gastric juice specimens from 10 healthy subjects and two patients with pernicious anaemia were used. The latter two specimens were obtained without pentagastric stimulation during routine investigations. Eight of the 10 specimens from healthy subjects were kindly donated by Dr Russell Bayly (Amersham International); the remaining two, which were used as controls, were collected from two healthy volunteers who were members of staff at St Bartholomew's Hospital. Gastric juice from healthy subjects was aspirated at 15, 20, and 45 minutes after an intramuscular injection of pentagastrin (6 pg/kg) was given. The juice was filtered and the pH adjusted to 10-0 with IN NaOH to inactivate the pepsin and 30 minutes later brought down to pH 7-4 with IN hydrochloric acid. The juice was stored in small aliquots-at -20°C until further use.
INTRINSIC FACTOR ANTIBODY
Sera from five patients with pernicious anaemia, all containing blocking antibody to intrinsic factor, were screened'5 for binding antibody to intrinsic factor and two were found to be positive. One of these was used throughout this study.
Sera from 30 healthy subjects and 15 patients with pernicious anaemia were studied. SEPHACRYL-S200 COLUMN CHROMATOGRAPHY Column chromatography was used to measure intrinsic factor activity in control gastric juice. The separation of intrinsic factor from R-protein is improved by incubating the gastric juice with serum containing binding antibody to intrinsic factor before loading the sample on to the column. The Cbl-intrinsic factorantibody complex then elutes in the excluded volume before the R-protein. ' 2 Gastric juice (100 pi) was incubated with CN-`7 (Co)Cbl one and a half times its predetermined binding capacity for 20 minutes at room temperature; 200 p1 of antibody serum was then 569 added and incubated for a further 20 minutes; the mixture was then cooled and applied to 2-5 x 100 cm column of Sephacryl-S200 (Pharmacia Fine Chemicals).
Columns were equilibrated and eluted at 4°C with 0-05 M sodium phosphate buffer (pH 7-4) containing 0 5 M sodium chloride and 0-02% sodium azide. Fractions (4 ml) were collected and the radioactivity of each fraction was determined in a well type gamma scintillation spectrometer. The amount of radioactivity in the protein peaks was converted to picograms of band CN-57(Co)Cbl using the appropriate specific activity. Total counts -background
This represents the amount of CN(7Co)Cbl bound to intrinsic factor in the sample. Intrinsic factor in gastric juice samples was measured by two methods-that ofGottlieb et al2 and that of Begley and Trachenberg.3 These methods require the blocking antibody to intrinsic factor and Cbi, respectively. Serum from one patient with pernicious anaemia, with a high titre of blocking antibody, and Cbi Dicyanide (Sigma Chemicals) were used. The two control gastric juice samples were also assayed for intrinsic factor using column chromatography.5
ASSAY OF BINDING ANTIBODY TO INTRINSIC FACTOR IN SERUM
To 400 y1 of buffer (pH 8-0) was added 5 u1 of 20% bovine albumin, 20 pl gastric juice, and 50y1 CN-"(Co)-Cbl. The tubes were incubated for 20 minutes at room temperature and 50 p1 of serum was added (positive reference with high titre antibody, negative control, or the unknown sample). Staphylococcal protein A slurry (500 Ml) was added and the tubes incubated for 20 minutes at 4°C, centrifuged at 1000 g, the gel washed once in buffer, and the pelleted gel counted. When the average counts obtained with the patient sample was at least twice as high as the counts obtained with the negative control, the assay was positive for the presence of intrinsic factor antibody in the patient serum Table 2 shows the results obtained by these three 572 Sourial higher than the average incidence (33%) expected in patients with pernicious anaemia tested at random. '6 7 The binding antibody could not be detected in any of the control subjects.
The advantage of this method of assay is that it can measure radioactive and potentially non-radioactive Cbl-bound intrinsic factor which facilitates binding studies of Cbl to intrinsic factor, carried out under different conditions, such as pH and proteolytic enzymes. This may be of particular value in investigating further the aetiology of Cbl malabsorption in pancreatic insufficiency and the mechanism by which bicarbonate and pancreatic proteases are necessary to degrade partially R-protein and enable Cbl to be bound exclusively to intrinsic factor.'8 Furthermore, screening patients for binding antibody to intrinsic factor eliminates false positive results caused by high serum Cbl concentrations, which can be a problem with the blocking intrinsic factor antibody test. It is predicted that in patients in whom serum IgG is greatly increased, falsely low results may be obtained. Work is in progress to develop an assay for serum Cbl using this technique.
The method is simple, sensitive, and accurate and suitable for use in any clinical laboratory using radioisotopes.
